European drug regulator reverses opinion on Eisai and Biogen’s Alzheimer’s drugnews2024-11-14T20:11:55+00:00November 14th, 2024|Endpoints News|
FDA approves PTC’s ultra-rare disease gene therapynews2024-11-14T05:11:24+00:00November 14th, 2024|Endpoints News|
FDA drug inspections have fallen from 2016 peak, GAO saysnews2024-11-13T18:19:08+00:00November 13th, 2024|Endpoints News|
FDA denies Ocaliva full approval, but Intercept hopes to keep drug on marketnews2024-11-12T19:14:56+00:00November 12th, 2024|Endpoints News|
FDA commissioner warns of risk to agency under RFK Jr. influencenews2024-11-12T19:08:54+00:00November 12th, 2024|Endpoints News|
Rapt cuts immunology program following clinical holdsnews2024-11-11T20:33:45+00:00November 11th, 2024|Endpoints News|
FDA action puts Chinese API manufacturer on import block listnews2024-11-08T20:09:48+00:00November 8th, 2024|Endpoints News|
Vaccine makers face headwinds from RFK, soft demand and Chinanews2024-11-07T18:25:57+00:00November 7th, 2024|Endpoints News|
FDA seeks to pull OTC nasal decongestant ingredient due to lack of efficacynews2024-11-07T17:02:53+00:00November 7th, 2024|Endpoints News|
California voters say yes to restrictions around 340B spendingnews2024-11-06T19:58:47+00:00November 6th, 2024|Endpoints News|
